Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 375

1.

Does seeing personal medical images change beliefs about illness and treatment in people with gout? A randomised controlled trial.

Krasnoryadtseva A, Dalbeth N, Petrie K.

Psychol Health. 2019 Jun 11:1-17. doi: 10.1080/08870446.2019.1626396. [Epub ahead of print]

PMID:
31184207
2.

Gout, flares, and allopurinol use: a population-based study.

Proudman C, Lester SE, Gonzalez-Chica DA, Gill TK, Dalbeth N, Hill CL.

Arthritis Res Ther. 2019 May 31;21(1):132. doi: 10.1186/s13075-019-1918-7.

3.

Mouse models for human hyperuricaemia: a critical review.

Lu J, Dalbeth N, Yin H, Li C, Merriman TR, Wei WH.

Nat Rev Rheumatol. 2019 May 22. doi: 10.1038/s41584-019-0222-x. [Epub ahead of print] Review.

PMID:
31118497
4.

Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual energy CT imaging study of a randomized controlled trial.

Dalbeth N, Billington K, Doyle A, Frampton C, Tan P, Aati O, Allan J, Drake J, Horne A, Stamp LK.

Arthritis Rheumatol. 2019 May 13. doi: 10.1002/art.40929. [Epub ahead of print]

PMID:
31081595
5.

How footwear is assessed in patient reported measures for people with arthritis. A scoping review.

Tehan PE, Carroll M, Dalbeth N, Rome K.

PM R. 2019 May 7. doi: 10.1002/pmrj.12182. [Epub ahead of print]

PMID:
31063639
6.

Effects of a footwear intervention on foot pain and disability in people with gout: a randomised controlled trial.

Frecklington M, Dalbeth N, McNair P, Morpeth T, Vandal AC, Gow P, Rome K.

Arthritis Res Ther. 2019 Apr 24;21(1):104. doi: 10.1186/s13075-019-1886-y.

7.

The anatomical pathology of gout: a systematic literature review.

Towiwat P, Chhana A, Dalbeth N.

BMC Musculoskelet Disord. 2019 Apr 1;20(1):140. doi: 10.1186/s12891-019-2519-y.

8.

"Come and live with my feet and you'll understand" - a qualitative study exploring the experiences of retail footwear in women with rheumatoid arthritis.

Tehan PE, Morpeth T, Williams AE, Dalbeth N, Rome K.

J Foot Ankle Res. 2019 Mar 14;12:15. doi: 10.1186/s13047-019-0328-z. eCollection 2019.

9.

Bovine bone particulates containing bone anabolic factors as a potential xenogenic bone graft substitute.

Musson DS, Gao R, Watson M, Lin JM, Park YE, Tuari D, Callon KE, Zhu M, Dalbeth N, Naot D, Munro JT, Cornish J.

J Orthop Surg Res. 2019 Feb 20;14(1):60. doi: 10.1186/s13018-019-1089-x.

10.

Liposome-Mediated Drug Delivery in Larval Zebrafish to Manipulate Macrophage Function.

Wu Z, Koh B, Lawrence LM, Kanamala M, Pool B, Svirskis D, Dalbeth N, Astin JW, Crosier KE, Crosier PS, Hall CJ.

Zebrafish. 2019 Apr;16(2):171-181. doi: 10.1089/zeb.2018.1681. Epub 2019 Feb 6.

PMID:
30724716
11.

Overlay repair with a synthetic collagen scaffold improves the quality of healing in a rat rotator cuff repair model.

Zhu M, Tay ML, Callon K, Tuari D, Zhao L, Dray M, Zhang J, Dalbeth N, Munro J, Young S, Coleman B, Patel D, Cornish J, Musson D.

J Shoulder Elbow Surg. 2019 May;28(5):949-958. doi: 10.1016/j.jse.2018.11.044. Epub 2019 Feb 2.

PMID:
30723031
12.

Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis.

Stewart S, Maxwell H, Dalbeth N.

Semin Arthritis Rheum. 2019 Jan 11. pii: S0049-0172(18)30618-8. doi: 10.1016/j.semarthrit.2019.01.004. [Epub ahead of print]

PMID:
30709689
13.

Experience of finding footwear and factors contributing to footwear choice in people with gout: a mixed methods study using a web-based survey.

Brenton-Rule A, Dalbeth N, Edwards NL, Rome K.

J Foot Ankle Res. 2019 Jan 8;12:3. doi: 10.1186/s13047-018-0313-y. eCollection 2019.

14.

Objectively-assessed foot and ankle characteristics in people with systemic lupus erythematosus: a comparison with age- and sex-matched controls.

Stewart S, Dalbeth N, Aiyer A, Rome K.

Arthritis Care Res (Hoboken). 2019 Jan 10. doi: 10.1002/acr.23832. [Epub ahead of print]

PMID:
30629828
15.

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank.

Narang RK, Topless R, Cadzow M, Gamble G, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2019 Jan 9;21(1):13. doi: 10.1186/s13075-018-1787-5.

16.

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.

Dalbeth N, Jones G, Terkeltaub R, Khanna D, Fung M, Baumgartner S, Perez-Ruiz F.

Arthritis Res Ther. 2019 Jan 7;21(1):8. doi: 10.1186/s13075-018-1788-4.

17.

No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat.

Stamp LK, Topless R, Miner JN, Dalbeth N, Merriman T.

Rheumatology (Oxford). 2018 Dec 27. doi: 10.1093/rheumatology/key423. [Epub ahead of print] No abstract available.

PMID:
30597115
18.

Genetic advances in gout: potential applications in clinical practice.

Tai V, Merriman TR, Dalbeth N.

Curr Opin Rheumatol. 2019 Mar;31(2):144-151. doi: 10.1097/BOR.0000000000000571.

PMID:
30575597
19.

Prevention and treatment of gout.

Stamp LK, Dalbeth N.

Nat Rev Rheumatol. 2019 Feb;15(2):68-70. doi: 10.1038/s41584-018-0149-7. No abstract available.

PMID:
30546062
20.

The Intentional Non-Adherence Scale (INAS): Initial development and validation.

Weinman J, Graham S, Canfield M, Kleinstäuber M, Perera AI, Dalbeth N, Petrie KJ.

J Psychosom Res. 2018 Dec;115:110-116. doi: 10.1016/j.jpsychores.2018.10.010. Epub 2018 Oct 21.

PMID:
30470309
21.

Basic Calcium Phosphate Crystals Induce Osteoarthritis-Associated Changes in Phenotype Markers in Primary Human Chondrocytes by a Calcium/Calmodulin Kinase 2-Dependent Mechanism.

Rong J, Pool B, Zhu M, Munro J, Cornish J, McCarthy GM, Dalbeth N, Poulsen R.

Calcif Tissue Int. 2019 Mar;104(3):331-343. doi: 10.1007/s00223-018-0494-1. Epub 2018 Nov 19.

PMID:
30456555
22.

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose.

Stamp LK, Chapman PT, Barclay ML, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2018 Nov 16;20(1):255. doi: 10.1186/s13075-018-1755-0.

23.

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

Stamp LK, Wright DFB, Dalbeth N.

Br J Clin Pharmacol. 2019 Jun;85(6):1378-1379. doi: 10.1111/bcp.13798. Epub 2018 Nov 12. No abstract available.

PMID:
30421456
24.

Gout in Aotearoa New Zealand: the equity crisis continues in plain sight.

Dalbeth N, Dowell T, Gerard C, Gow P, Jackson G, Shuker C, Te Karu L.

N Z Med J. 2018 Nov 9;131(1485):8-12. No abstract available.

PMID:
30408813
25.

Altered expression of the core circadian clock component PERIOD2 contributes to osteoarthritis-like changes in chondrocyte activity.

Rong J, Zhu M, Munro J, Cornish J, McCarthy GM, Dalbeth N, Poulsen RC.

Chronobiol Int. 2019 Mar;36(3):319-331. doi: 10.1080/07420528.2018.1540493. Epub 2018 Nov 7.

PMID:
30403881
26.

Patient education and engagement in treat-to-target gout care.

Neogi T, Dalbeth N.

Lancet. 2018 Oct 20;392(10156):1379-1381. doi: 10.1016/S0140-6736(18)32415-2. No abstract available.

27.

Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts.

Major TJ, Topless RK, Dalbeth N, Merriman TR.

BMJ. 2018 Oct 10;363:k3951. doi: 10.1136/bmj.k3951.

28.

Greater insulin response to acute fructose ingestion among Māori and Pacific people compared to European people living in Aotearoa New Zealand.

Murphy R, Gamble GD, House M, Pool B, Horne A, Merriman TR, Dalbeth N.

Intern Med J. 2019 Feb;49(2):196-202. doi: 10.1111/imj.14135.

PMID:
30298971
29.

Reply.

Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R.

Arthritis Rheumatol. 2019 Mar;71(3):481-482. doi: 10.1002/art.40742. Epub 2019 Feb 7. No abstract available.

PMID:
30295436
30.

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

Stamp LK, Wallace M, Roberts RL, Frampton C, Miner JN, Merriman TR, Dalbeth N.

Drug Metab Pharmacokinet. 2018 Dec;33(6):241-242. doi: 10.1016/j.dmpk.2018.09.002. Epub 2018 Sep 18. No abstract available.

PMID:
30274827
32.

Monosodium urate crystals reduce osteocyte viability and indirectly promote a shift in osteocyte function towards a proinflammatory and proresorptive state.

Chhana A, Pool B, Callon KE, Tay ML, Musson D, Naot D, McCarthy G, McGlashan S, Cornish J, Dalbeth N.

Arthritis Res Ther. 2018 Sep 10;20(1):208. doi: 10.1186/s13075-018-1704-y.

33.

The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.

Kapetanovic MC, Nilsson P, Turesson C, Englund M, Dalbeth N, Jacobsson L.

Arthritis Res Ther. 2018 Aug 29;20(1):190. doi: 10.1186/s13075-018-1697-6.

34.

The relationship between ferritin and urate levels and risk of gout.

Fatima T, McKinney C, Major TJ, Stamp LK, Dalbeth N, Iverson C, Merriman TR, Miner JN.

Arthritis Res Ther. 2018 Aug 15;20(1):179. doi: 10.1186/s13075-018-1668-y.

35.

Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Rheumatology (Oxford). 2018 Dec 1;57(12):2183-2189. doi: 10.1093/rheumatology/key237.

PMID:
30107437
36.

Foot and ankle characteristics in systemic lupus erythematosus: A systematic review and meta-analysis.

Stewart S, Brenton-Rule A, Dalbeth N, Aiyer A, Frampton C, Rome K.

Semin Arthritis Rheum. 2019 Apr;48(5):847-859. doi: 10.1016/j.semarthrit.2018.07.002. Epub 2018 Aug 6.

PMID:
30093237
37.

Combination urate-lowering therapy in the treatment of gout: What is the evidence?

Perez-Ruiz F, Dalbeth N.

Semin Arthritis Rheum. 2019 Feb;48(4):658-668. doi: 10.1016/j.semarthrit.2018.06.004. Epub 2018 Jun 20. Review.

PMID:
30075988
38.

Altered N-methyl D-aspartate receptor subunit expression causes changes to the circadian clock and cell phenotype in osteoarthritic chondrocytes.

Kalev-Zylinska ML, Hearn JI, Rong J, Zhu M, Munro J, Cornish J, Dalbeth N, Poulsen RC.

Osteoarthritis Cartilage. 2018 Nov;26(11):1518-1530. doi: 10.1016/j.joca.2018.06.015. Epub 2018 Jul 19.

PMID:
30031924
39.

Febuxostat for the treatment of hyperuricaemia in gout.

Robinson PC, Dalbeth N.

Expert Opin Pharmacother. 2018 Aug;19(11):1289-1299. doi: 10.1080/14656566.2018.1498842. Epub 2018 Jul 19.

PMID:
30024787
40.

Characteristics of footwear worn by people with systemic lupus erythematosus: a comparison with age- and sex-matched healthy controls: a pilot study.

Stewart S, Keys M, Brenton-Rule A, Aiyer A, Dalbeth N, Rome K.

J Foot Ankle Res. 2018 Jul 5;11:38. doi: 10.1186/s13047-018-0280-3. eCollection 2018.

41.

Mediation analysis to understand genetic relationships between habitual coffee intake and gout.

Hutton J, Fatima T, Major TJ, Topless R, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2018 Jul 5;20(1):135. doi: 10.1186/s13075-018-1629-5.

42.

Keeping Up with the Applications: Lessons Learned Evaluating Gout Apps.

Kieser A, Dalbeth N, Serlachius A.

Telemed J E Health. 2019 Apr;25(4):272-273. doi: 10.1089/tmj.2018.0091. Epub 2018 Jul 3.

PMID:
29969385
43.

Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin.

Roberts RL, Wallace MC, Harrison AA, White D, Dalbeth N, Stamp LK, Ching D, Highton J, Merriman TR, Robinson PC, Brown MA, Stebbings SM.

PeerJ. 2018 Jun 26;6:e5088. doi: 10.7717/peerj.5088. eCollection 2018.

45.

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2019 Mar;71(3):427-434. doi: 10.1002/acr.23607.

PMID:
29799677
46.

Googling Gout: Exploring Perceptions About Gout Through a Linguistic Analysis of Online Search Activities.

Jordan KN, Pennebaker JW, Petrie KJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2019 Mar;71(3):419-426. doi: 10.1002/acr.23598.

PMID:
29781577
47.

An update on the genetics of hyperuricaemia and gout.

Major TJ, Dalbeth N, Stahl EA, Merriman TR.

Nat Rev Rheumatol. 2018 Jun;14(6):341-353. doi: 10.1038/s41584-018-0004-x. Review.

PMID:
29740155
48.

Ankle joint function during walking in tophaceous gout: A biomechanical gait analysis study.

Carroll M, Boocock M, Dalbeth N, Stewart S, Frampton C, Rome K.

Gait Posture. 2018 Jun;63:150-153. doi: 10.1016/j.gaitpost.2018.04.020. Epub 2018 Apr 17.

PMID:
29734124
49.

Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.

Krishnan M, Major TJ, Topless RK, Dewes O, Yu L, Thompson JMD, McCowan L, de Zoysa J, Stamp LK, Dalbeth N, Harré Hindmarsh J, Rapana N, Deka R, Eng WWH, Weeks DE, Minster RL, McGarvey ST, Viali S, Naseri T, Sefuiva Reupena M, Wilcox P, Grattan D, Shepherd PR, Shelling AN, Murphy R, Merriman TR.

Diabetologia. 2018 Jul;61(7):1603-1613. doi: 10.1007/s00125-018-4623-1. Epub 2018 May 2.

PMID:
29721634
50.

The nomenclature of the basic disease elements of gout: A content analysis of contemporary medical journals.

Bursill D, Taylor WJ, Terkeltaub R, Dalbeth N.

Semin Arthritis Rheum. 2018 Dec;48(3):456-461. doi: 10.1016/j.semarthrit.2018.03.017. Epub 2018 Mar 28.

PMID:
29706241

Supplemental Content

Loading ...
Support Center